Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Lonza Visp, Switzerland is seeking an MSAT Bioconjugates Process Expert (f/m/d) at 80-100% to join our Bioconjugation Manufacturing team in Visp. The role focuses on delivering process expertise and operations excellence to manufacture high-quality biopharma APIs on site.
You'll collaborate with Process Development, Operations, QA and QC, support tech transfer and continuous improvement, and contribute to CPV and APQR documentation. Fluency in English is required; German is a plus.
The actual location of this job is in Visp, Switzerland.
Relocation assistance is available for eligible candidates and their families, if needed.
Join our Bioconjugation Manufacturing team in Visp and play a key role in delivering innovative biopharma manufacturing solutions. This is an exciting opportunity to combine scientific expertise, process excellence, and cross-functional collaboration to support the production of life-changing therapies.
This role is based on site. Working together in person supports close, real-time collaboration and the technical precision needed to manufacture medicines to the highest quality and safety standards.
The full list of our global benefits can be found here: https://www.lonza.com/careers/benefits
At Lonza, our people are our greatest strength. With 30+ sites across five continents, our globally connected teams work together every day to manufacture the medicines of tomorrow. Our core values of Collaboration, Accountability, Excellence, Passion and Integrity reflect who we are and how we work together. Everyone’s ideas, big or small, have the potential to improve millions of lives, and that’s the kind of work we want you to be part of. Innovation thrives when people from all backgrounds bring their unique perspectives to the table. At Lonza, we value diversity and are committed to creating an inclusive environment for all employees. If you’re ready to help turn our customers’ breakthrough ideas into viable therapies, we look forward to welcoming you on board.